Anthropic reports five cases of possible biological misuse

Anthropic · Company report

Read the source (opens in a new tab)
What happened
Anthropic published five case studies of accounts using Claude in ways that could support biological weapons development, and banned the accounts it detected.
Key points
  • Anthropic says that, to its knowledge, no private company had yet publicly shared evidence of potential misuse of its platform for biological weapons development.
  • In one case, Opus 5 drafted a complete orthopoxvirus immune-evasion grant application in about an hour for a reseller relay serving a dozen customers.
  • Other cases involved chikungunya gain-of-function work, avian influenza mammalian-adaptation planning, a venom peptide pipeline, and computational toxin redesign for a national program.
  • It says biology is dual use and sophisticated actors exploit that for "plausible deniability," hiding intent in requests that look beneficial.
Evidence
Company report on activity it detected on its own platform, within a threat report covering December 2025 to August 2026. It withholds the institutions and countries involved.
Uncertain
Anthropic says those implicated "are working scientists" and does "not assert that they intended harm." The page prints only "September 2026"; our day comes from its CMS timestamps and file names.

See it in the latest record